Meeting
2022 ASCO Genitourinary Cancers Symposium
Prostate specific antigen dynamics and prostate cancer risk: A population-based study.
Authors
Amanda Elizabeth Hird
Division of Urology, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada
Amanda Elizabeth Hird , Refik Saskin , Lisa Del Giudice , Girish S. Kulkarni , Robert Nam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 239)
DOI
10.1200/JCO.2022.40.6_suppl.239
Abstract #
239
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
PSA velocity to predict clinical progression in African American and non-Hispanic White patients with low-risk prostate cancer undergoing active surveillance.
First Author: Juan Javier-Desloges
Poster
2012 Genitourinary Cancers Symposium
Circulating tumor cells (CTCs) as a predictor of metastatic disease in patients with biochemical recurrence (BR) of prostate cancer with equivocal scan results.
First Author: Jeanny B. Aragon-Ching
Poster
2024 ASCO Genitourinary Cancers Symposium
i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for prostate cancer.
First Author: Alexandru George Floares
Poster
2024 ASCO Genitourinary Cancers Symposium
A novel blood-based mRNA genomic test for screening, early detection, prognosis, and monitoring of prostate cancer: A multicenter study.
First Author: Yutaka Hashimoto